Efficacy and Safety of Rivaroxaban for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation

NCT00494871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1280

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: Warfarin
DRUG: Rivaroxaban placebo
DRUG: Warfarin placebo

Sponsor

Bayer

Collaborators

[object Object]